PATHOGENETIC ASPECTS OF IMPAIRED BLOOD RHEOLOGICAL PROPERTIES IN THE BRAIN AND NERVOUS SYSTEM IN BLUNT CLOSED HEAD TRAUMA

Authors

  • Boboyeva Z.N.,Madraximov Jasurbek Tashkent State Medical University, Author

Keywords:

Numerous

Abstract

In the fields of modern neurosurgery, hematology, hemorheology, and intensive care, blunt closed head trauma (traumatic brain injury — TBI) remains one of the most severe and pressing clinical challenges [69, 96]. According to the latest statistical data from the World Health Organization, millions of people worldwide sustain TBI each year, making it one of the leading causes of death and long-term disability [69, 96]. In the Republic of Uzbekistan, the incidence of TBI continues to rise steadily due to road traffic accidents, occupational injuries, domestic incidents, and sports trauma, resulting in severe clinical complications in a significant portion of the population — including disturbances of blood rheological properties in the brain and nervous system [96, 69]. These disturbances represent one of the key pathogenetic mechanisms of secondary brain injury, leading to microcirculatory failure, cerebral ischemia, thrombosis, and hemorrhagic progression [8, 122].

References

1. Abdelmalik PA, Boorman DW, Tracy J, Jallo J, Rincon F. Acute traumatic coagulopathy accompanying isolated traumatic brain injury is associated with worse long-term functional and cognitive outcomes. Neurocrit Care. 2016;24(3):361–370.

2. Albert V, Subramanian A, Agrawal D, Pati HP, Gupta SD, Mukhopadhyay AK. Acute traumatic endotheliopathy in isolated severe traumatic brain injury and its effects on clinical outcomes. Med Sci (Basel). 6(5):2018.

3. Alexandrova A, Antonova N. Correlation between erythrocyte aggregation and adhesion of leukocytes to the endothelium. Ser Biomech. 2016;30:35–42.

4. Alexandrova A, Antonova N, Kyulavska M, Velcheva I, Ivanov I, Zvetkova E. Hemorheological and atomic force microscopy studies on experimental clot formations in patients with type 2 diabetes mellitus. Ser Biomech. 2018;32:63–73.

5. Alexandrova A, Antonova N, Muravyov AV, Khristov K, Velcheva V. Evaluation of the microrheological properties of blood in patients with type 2 diabetes mellitus using a developed flow microchamber. Ser Biomech. 2020;34:10–17.

6. Anglin CO, Spence JS, Warner MA, et al. Effects of platelet and plasma transfusion on outcome in traumatic brain injury patients with moderate bleeding diatheses. J Neurosurg. 2013;118:676–686.

7. Antonova N, Alexandrova A, Melnikova G, et al. Micromechanical properties of peripheral blood cells (erythrocytes, lymphocytes and neutrophils) in patients with diabetes mellitus type 2, examined with atomic force microscope (AFM). Ser Biomech. 2019;32:3–11.

8. Antonova N, Velcheva V, Paskova V. Hemorheological and microvascular disturbances in patients with type 2 diabetes mellitus. Clin Hemorheol Microcirc. 2022;81:325–341.

9. Asahi M, Wang X, Mori T, et al. Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia. J Neurosci. 2001;21:7724–7732.

10. Briggs A, Gates JD, Kaufman RM, Calahan C, Gormley WB, Havens JM. Platelet dysfunction and platelet transfusion in traumatic brain injury. J Surg Res. 2015;193:802–806.

11. Brown LM, Call MS, Knudson MM, Cohen MJ, et al. (Trauma Outcomes Group). A normal platelet count may not be enough: the impact of admission platelet count on mortality and transfusion in severely injured trauma patients. J Trauma. 2011;71(2 Suppl 3):S337–S342.

12. Campwala I, Guyette FX, Brown JB, et al. Evaluating resuscitation burden after trauma from two randomized controlled trials. Sci Rep. 2023;13(1106).

13. Cannon JW, Khan MA, Raja AS, et al. Damage control resuscitation in patients with severe traumatic hemorrhage: A practice management guideline from the Eastern Association for the Surgery of Trauma. J Trauma Acute Care Surg. 2017;82:605–617.

14. Cardenas JC, Matijevic N, Baer LA, Holcomb JB, Cotton BA, Wade CE. Elevated tissue plasminogen activator and reduced plasminogen activator inhibitor promote hyperfibrinolysis in trauma patients. Shock. 2014;41(6):514–521.

15. Castellino FJ, Chapman MP, Donahue DL, et al. Traumatic brain injury causes platelet adenosine diphosphate and arachidonic acid receptor inhibition independent of hemorrhagic shock in humans and rats. J Trauma Acute Care Surg. 2014;76(5):1169–1176.

16. Chang R, Cardenas JC, Wade CE, Holcomb JB. Advances in the understanding of trauma-induced coagulopathy. Blood. 2016;128(8):1043–1049.

17. Chapman MP, Moore EE, Moore HB, et al. Overwhelming tPA release, not PAI-1 degradation, is responsible for hyperfibrinolysis in severely injured trauma patients. J Trauma Acute Care Surg. 2016;80(1):16–23.

18. Chelladurai Y, Stevens KA, Haut ER, et al. Venous thromboembolism prophylaxis in patients with traumatic brain injury: A systematic review. F1000Res. 2013;2(132).

19. Cluitmans JC, Chokkalingam V, Janssen AM, Brock R, Huck WT, Bosman GJ. Alterations in red blood cell deformability during storage: A microfluidic approach. BioMed Res Int. 2014;2014:764268.

20. Cole E, Davenport R, Willett K, Brohi K. Tranexamic acid use and outcomes in severely injured civilian patients: A prospective cohort study. Ann Surg. 2015;261:390–394.

21. Connelly CR, Van PY, Hart KD, et al. Thrombelastography-based dosing of enoxaparin for thromboprophylaxis in trauma and surgical patients: A randomized clinical trial. JAMA Surg. 2016;151(e162069).

[References 22–135 continue in the original article]

Downloads

Published

2026-05-23